Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
NCT04710576· Phase 2· Syndax Pharmaceuticals· Source
Contact: Syndax Pharmaceuticals
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error